Consistent with our results, it has been found that the 17-AAG not only destabilizes the HIF-1α protein in prostate cancer cells but also disrupts STAT3- HIF-1α activation axis in pancreatic and gastric cancer cells [37, 38]. Here, HIF1A is linked to prostate cancer.